Media Advisory: Ten life sciences companies to pitch emerging health technologies at UB on Sept. 10

UB's Center of Excellence in Bioinformatics and Life Sciences. A banner across the bridge between two buildings says "Innovation Starts Here.".

NewYorkBIO event brings biotech founders, investors and industry leaders to Buffalo

By Daniel Robison

Release Date: September 3, 2026

Print

BUFFALO, N.Y. – Ten early-stage life science and biotech companies will present their technologies during NewYorkBIO’s Buffalo Mini-Pitch Day at the University at Buffalo, hosted by UB Business and Entrepreneur Partnerships.

Each will pitch to a panel of judges and receive real-time feedback in front of investors, entrepreneurs and life sciences industry leaders.

News media will have the opportunity to speak with founders about their companies and technologies.

Who: Participating companies and presenters include:

  • Kevin Macwan, Sensible Vascular – single-pass stroke clot removal
  • Karla Paniagua, NexOnco.AI – AI for cancer prognosis
  • Ernest Smith, Immunotolerx – immune tolerance therapies for autoimmune disease
  • Satish Kandlikar, BiRed Imaging Inc. – AI-assisted breast cancer detection
  • Kelly Cycon, Axenica Bioscience LLC – viral reference materials for diagnostics
  • William Mangione, Meditati Inc. – AI drug discovery for opioid use disorder
  • Samara Barend, AION Biosystems – continuous temperature monitoring for early infection detection
  • Tim Mikhelashvili, Amedea Pharma – life sciences performance analytics
  • Jonathan Lovell, POP Biotechnologies – rapid-response vaccine technology
  • Kerry Poppenberg, Neurovascular Diagnostics, Inc. – blood-based diagnostics for unruptured brain aneurysms

The participating companies represent a mix of Western New York startups. Rochester-based BiRed Imaging was co-founded by Rochester Institute of Technology professor Satish Kandlikar, and Immunotolerx — a portfolio company of Empire Discovery Institute — will also be among the presenters.

Several companies have Buffalo and UB connections, including POP Biotechnologies, a UB spinout led by biomedical engineering professor Jonathan Lovell; Sensible Vascular, a Canadian company that recently established a presence at UB’s Center of Excellence in Bioinformatics and Life Sciences (CBLS); Meditati, a spinout founded by UB biomedical informatics professor Ram Samudrala; Immunotolerx, which licenses technology invented in the laboratory of UB pharmaceutical sciences professor Sathy Balu-Iyer; and Neurovascular Diagnostics, a UB spinout developing a blood test to screen for unruptured brain aneurysms.

When: Thursday, Sept. 10, 2026, 2-5:30 p.m. Networking Reception to follow.

Where: UB Center of Excellence in Bioinformatics and Life Sciences (CBLS), 701 Ellicott St., Buffalo, N.Y. 14203.

Media Contact Information

Media Relations (University Communications)
330 Crofts Hall (North Campus)
Buffalo, NY 14260-7015
Tel: 716-645-6969
ub-news@buffalo.edu

Contact Us

Do you have questions or comments for the Office of the Provost? Let us know your thoughts and we’ll be happy to get back to you.

Contact Us>

OUR RESEARCH MAKES LIFE BETTER

graduate student inspects a sample in a laboratory.

As one of the nation's leading public research universities, UB has been changing the world through its research and scholarship for decades. Today, UB continues to deliver ideas, discoveries and innovations for a safer, healthier and brighter future.

Explore UB’s pioneering research>